New European AML agency to be based in Germany
By 
Kyle Brasseur2024-02-27T12:43:00
The European Union’s recently approved Anti-Money Laundering Authority (AMLA) will be based in Frankfurt, Germany, and begin operations in 2025.
The Council of the European Union announced the development Thursday. It said AMLA will be comprised of more than 400 staff members.
The creation of AMLA was proposed as part of a July 2021 package of rules presented by the European Commission to strengthen the efficiency of anti-money laundering and countering the financing of terrorism (AML/CFT) efforts in the region. The agency received preliminary approval in December, paving its way toward final adoption.
Related articles
-
News BriefBaFin fines Commerzbank $1.6M over supervision, AML lapses
Germany’s financial supervisory authority issued total fines of €1.45 million (U.S. $1.6 million) against Commerzbank AG to settle allegations of inadequate monitoring and anti-money laundering controls.
-
PremiumAMLA impact dependent on national collaboration
The impact of the Anti-Money Laundering Authority to improve the coordination and success of AML activities will be largely indirect, depending on its influence over European national governments continuing to supervise most EU financial services firms.
-
News BriefNew European AML agency nearing adoption
A new agency to supervise high-risk financial institutions across the European Union regarding their anti-money laundering and countering the financing of terrorism activities gained provisional approval.
More from Regulatory Policy
-
PremiumEU moves to simplify GDPR and AI Act obligations, raising compliance questions for companies
For the past decade, Europe has led in creating strong but flexible rules for data use and safe AI development. The EU’s new plans to simplify key data privacy and AI governance measures have received a mixed response.
-
News BriefSEC exam priorities for 2026 signal heightened focus on firmwide compliance
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
-
ArticlePharma sector boom puts pressure on compliance to counter financial crime
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.